Oncologix Tech Stock Performance
| OCLG Stock | USD 0.0001 0.00 0.00% |
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Oncologix Tech are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Oncologix Tech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable essential indicators, Oncologix Tech is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Total Cashflows From Investing Activities | -913.00 |
Oncologix |
Oncologix Tech Relative Risk vs. Return Landscape
If you would invest 0.01 in Oncologix Tech on September 12, 2024 and sell it today you would earn a total of 0.00 from holding Oncologix Tech or generate 0.0% return on investment over 90 days. Oncologix Tech is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Oncologix, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Oncologix Tech Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Oncologix Tech's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Oncologix Tech, and traders can use it to determine the average amount a Oncologix Tech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| OCLG |
Based on monthly moving average Oncologix Tech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Oncologix Tech by adding Oncologix Tech to a well-diversified portfolio.
Oncologix Tech Fundamentals Growth
Oncologix Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Oncologix Tech, and Oncologix Tech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Oncologix Pink Sheet performance.
| Return On Asset | -0.12 | |||
| Profit Margin | (0.38) % | |||
| Operating Margin | (0.13) % | |||
| Current Valuation | 3.18 M | |||
| Shares Outstanding | 340.13 M | |||
| Price To Earning | (0.03) X | |||
| Price To Sales | 0.17 X | |||
| Revenue | 2.85 M | |||
| EBITDA | (572.25 K) | |||
| Cash And Equivalents | 86.31 K | |||
| Total Debt | 3.97 M | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (24.2 K) | |||
| Earnings Per Share | (0.01) X | |||
| Total Asset | 1.5 M | |||
| Retained Earnings | (49.86 M) | |||
| Current Asset | 1.31 M | |||
| Current Liabilities | 4.67 M | |||
About Oncologix Tech Performance
By analyzing Oncologix Tech's fundamental ratios, stakeholders can gain valuable insights into Oncologix Tech's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Oncologix Tech has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Oncologix Tech has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Oncologix Tech, Inc., a diversified medical holding company, provides health care services in the United States. Oncologix Tech, Inc. was founded in 1995 and is based in Lafayette, Louisiana. Oncologix Tech operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 191 people.Things to note about Oncologix Tech performance evaluation
Checking the ongoing alerts about Oncologix Tech for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Oncologix Tech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Oncologix Tech generated a negative expected return over the last 90 days | |
| Oncologix Tech has some characteristics of a very speculative penny stock | |
| Oncologix Tech has a very high chance of going through financial distress in the upcoming years | |
| Oncologix Tech currently holds 3.97 M in liabilities. Oncologix Tech has a current ratio of 0.27, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Oncologix Tech until it has trouble settling it off, either with new capital or with free cash flow. So, Oncologix Tech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Oncologix Tech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Oncologix to invest in growth at high rates of return. When we think about Oncologix Tech's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 2.85 M. Net Loss for the year was (2.37 M) with profit before overhead, payroll, taxes, and interest of 614.41 K. | |
| Oncologix Tech currently holds about 86.31 K in cash with (24.2 K) of positive cash flow from operations. |
- Analyzing Oncologix Tech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Oncologix Tech's stock is overvalued or undervalued compared to its peers.
- Examining Oncologix Tech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Oncologix Tech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Oncologix Tech's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Oncologix Tech's pink sheet. These opinions can provide insight into Oncologix Tech's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Oncologix Pink Sheet analysis
When running Oncologix Tech's price analysis, check to measure Oncologix Tech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncologix Tech is operating at the current time. Most of Oncologix Tech's value examination focuses on studying past and present price action to predict the probability of Oncologix Tech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncologix Tech's price. Additionally, you may evaluate how the addition of Oncologix Tech to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |